- Home
- ALXO vs CEPL Comparison
ALXO vs CEPL Comparison
Compare ALXO & CEPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALXO | CEPL |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.9M | 238.9M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ALXO | CEPL |
|---|---|---|
| Price | $1.98 | $5.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 953.4K | 430.8K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $106,004,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 23.89 |
| 52 Week Low | $0.96 | $5.72 |
| 52 Week High | $2.66 | $12.32 |
Technical Indicators
Market Signals| Indicator | ALXO | CEPL |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 34.30 |
| Support Level | $1.90 | N/A |
| Resistance Level | $2.17 | $6.84 |
| Average True Range (ATR) | 0.09 | 0.64 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 37.50 | 12.45 |
Price Performance
Historical ComparisonAbout ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About CEPL Capstone Energy Plus Inc. Common Stock
Capstone Energy+ Inc provides behind-the-meter clean energy solutions for industrial and commercial operations, as well as solutions for artificial intelligence (AI) and data center applications. It develops and manufactures oil-free, microturbine-based power generation systems designed to operate on a range of gaseous fuels.